NDRA 10-Q: SEC filing
ENDRA Life Sciences
Filed with the SEC on · accession 0001213900-26-120776
NDRA filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -3.9% by the first close after the filing.
Summary of the filing
ENDRA Life Sciences filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing ongoing operating losses, financing activities including private placements and ATM agreements, and significant dilution from warrants and preferred stock.
Key details
How NDRA stock reacted
Close before
$4.50
Nov 13, 2026
First close after
-3.89%
$4.32
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for NDRA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NDRA?
Click hereFrequently asked questions
What did NDRA file with the SEC on Nov 16, 2026?
NDRA filed a 10-Q (SEC filing). ENDRA Life Sciences filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing ongoing operating losses, financing activities including private placements and ATM agreements, and significant dilution from warrants and preferred stock.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did NDRA stock react to this filing?
NDRA closed at $4.50 before the filing and $4.32 on Nov 16, 2026 (-3.89%).
Other NDRA SEC filings
- 8-K · SEC filingNov 16, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- SCHEDULE 13D · SEC filingOct 8, 2026
- S-4 · SEC filingOct 2, 2026
- 8-K · AcquisitionOct 1, 2026
- 8-K · SEC filingAug 17, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · Regulatory actionJul 9, 2026
- 8-K · AcquisitionJun 26, 2026
- 144 · Insider sale plannedJun 25, 2026
Get alerts when NDRA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days